@Aiims1742 @skopetz @DrShubhamPant @DavidHongMD Every vehicle on the island!

Our expert team's new publication on the Association of personalized and tumor-informed #ctDNA with patient survival outcomes in #pancreaticcancer @UCSDCancer

RT @jitcancer: New #JITC case report: Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells

Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells | Journal for ImmunoTherapy of Cancer

RT @MadameSurgeon: It’s official! It is my absolute privilege to be named as the Director of the Moores Comprehensive Cancer Center at UCSD…

RT @clary_bryan: UCSD Faculty member, Dr. Andy Lowy delivering the MSKCC David Rubenstein Award Lecture in New York City. Prestigious award…

RT @TotalHealthConf: Day 1 at #ESMOWest2023 was a blast! 🚀 A special thank you to our fantastic speakers today for sharing their incredibl…

RT @Dr_R_Kurzrock: Honored to chair this outstanding conference. 💥🔥🌈🎯 Nigel and Deanna Russell at Genome Web did a great job. The speaker…

RT @MIBE_TUM: Physician-scientist Prof. Maximilian Reichert uses #organoid technology to model #pancreatic cancer in order to develop new t…

@PatelOncology ctDNA has the potential to differentiate radiologic progression vs flare:

RT @Cosimo_Commisso: Plus chat with GI medical oncologist @gregorybotta from @UCSDCancer and pancreatic cancer survivor Russ Gold @Justice_…

RT @pashtoonkasi: 🆕Just published🗞️ One of the 1st insights on🩸#ctDNA in patients with #AnalCancer. Of value in a number of ways & clinical…

RT @BHuffmanMD: Happy to share our publication on tumor-informed circulating tumor DNA in patients with gastric, GEJ, and esophageal cancer…

RT @pashtoonkasi: 👇🏾🆕 @JCOPO_ASCO Delighted to be a part of this important project - one of the largest datasets providing in-depth insight…

RT @DocmeetingsOnco: GI Cancers Series Part 3: Immunotherapy and Targeted Therapy in GI Cancers CURE® 12/6/22, 6:00 PM GMT -4 summer John…

ASCO 2022 on the Multicenter Phase Ib US Trial of Salvage CT041 CLDN18.2-Specific CAR T-Cell Therapy for Advanced Gastric and Pancreatic Adenocarcinoma | VuMedi via @vumedi

RT @sbpdiscovery: We are honored to announce that Erkki Ruoslahti has been named a #LaskerLaureate. The #LaskerAward is the most prestigio…